According to Daily Pioneer, the third most common cancer found in males is prostate cancer.
Prostate cancer is the continual growth of the cells in the prostate gland. This gland is present in men, and its primary function is the nourishment of sperm. Within the prostate gland are the Leydig cells. These cells secrete a hormone called androgen.
Androgen is responsible for male sexual and reproductive functions. It also controls secondary sexual characteristics like pelvic development, growth of body hair, muscular build, matured testicles, etc. It also regulates the growth of usual as well as cancerous cells. Sometimes, androgen receptors cannot manage the development of cancer cells, and this is where various cancer treatment methods come into play. Cancer treatments function as an anti-androgen incentive that inhibits the growth of cancerous cells in the prostate gland.
In recent years, bicalutamide is being used to limit the overproduction of androgen hormones to curtail prostate cancer cases. Many CDMO companies in India have directed their drug development and manufacturing process towards bicalutamide for its stated treatment benefits.
Pharmaceutical companies are increasingly relying on CDMOs when it comes to the complexity of drug development and manufacturing, like bicalutamide.
Having a CDMO partner can be a great resource with many benefits for pharmaceutical companies to focus their efforts and resources on initiatives that move their company forward, whether navigating the FDA’s highly regulated drug development framework or scaling production to meet deadlines and demand.
One cancer treatment method that doctors often prescribe is chemotherapy. However, prostate cancer cells develop immunity to chemotherapy. As a solution, the top oncology pharma companies in India introduced bicalutamide or BCLT drugs.
Bicalutamide is a cancer treatment drug that stops mingling testosterone with cancer cells. It also hampers the growth of cancer cells by shrinking them and cutting down their growth rate.
How is bicalutamide an effective drug therapy for slowing down cancer cell growth?
The best method to cure cancer is to slow down the growth of cancer cells.
Bicalutamide is a drug therapy that blocks androgen receptors and stabilizes prostate tumours. Since the CDMO companies in India perform both research and development of effective medications, the complete manufacturing process of bicalutamide lies in their hands.
What are the uses of bicalutamide?
Bicalutamide pauses the growth of prostate cancer cells within the glands. It cuts down the hormone secretion rate reducing the hormone growth process.
Pinnacle is a top pharma contract manufacturer in India that offers bicalutamide research and development services for prominent pharmaceutical companies.
For more information about the drug, consult your doctor or pharmacist before consumption.
What are the side effects of bicalutamide?
After researching the anti-androgen bicalutamide, the top oncology pharma companies in India list down the side effects of a bicalutamide that pharma companies should look into while prescribing the drugs.
Side effects of bicalutamide-
- Nausea
- Vomiting
- Swollen breasts
- Hot flashes
- Headache
- Diarrhea
- Upset stomach
- Increased blood pressure
- Short of breath
- Drowsiness
- Trouble sleeping
- Excessive gain or loss in weight
- Blood in urine
- Erectile dysfunction
- Increased frequency of urination
- Pain during urination
These side effects are acute. However, if you experience anything like the symptoms mentioned below, contact your doctors straightaway.
- Intense tiredness
- Unusual bleeding
- Short of energy
- Yellowish skin
- Loss of appetite
- Chest pain
What should your doctor know?
Before you begin the consumption of bicalutamide, ensure that you inform your doctor regarding any side effects or prior diseases you might have.
Some specific information that your doctor should know about you are-
- If you’re allergic to any of the components of bicalutamide.
- You have any liver disease.
- Give a copy of your supplements and vitamins to your doctor or pharmacist.
Important:
Bicalutamide is for male consumption only. If taken by women, it can harm the fetus when pregnant. Whether you’re pregnant or not, bicalutamide is exclusively for men.
Conclusion
Bicalutamide is a responsive drug therapy for treating cancer cells in the prostate gland. It belongs to the oncology category and is an androgen receptor inhibitor. It blocks the action of the prostate gland, limiting the nourishment of sperm for the time being.
As a pharma contract manufacturer in India, Pinnacle maintains the highest quality for the fight against stage D2 metastatic prostate cancer.
